Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

  • La actividad es la pintura. [undo]
  • Ο ασθενής σας δίνει λεπτομερές ιατρικό ιστορικό [undo]
  • ADAMTS13 activity [undo]
  • Επιλογή 1: A και Γ είναι σωστά [undo]
  • Ο ασθενής έχει αυξημένα ηπατικά ένζυμα [undo]
  • Start [undo]
  • Exploring the Desire to Remain Productive Despite Chronic Illness [undo]
  • Νευρολογικη εκτιμηση [undo]
  • Admission [undo]
  • steroids – diuretics – bili and discuss [undo]
  • A microscope that uses electron source to magnify objects [undo]
  • Bisoprolol [undo]
  • Respuesta 2: hipotónica es agua destilada, hipertónica es 6% NaCl, isotónica es 0.9% NaCl [undo]
  • Empagliflozin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21112
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway